Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 7/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | F2R | P25116 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19753674 | 0.84 | PTGS1 (0.35) | PTGS2PTGS1ALOX5LMNARECQL | |
| SCHEMBL21297713 | 0.83 | HCAR2 (0.41) | PTGS2HCAR2LMNARECQLMEN1 | |
| SCHEMBL20913297 | 0.76 | ALDH1A1 (0.43) | HCAR2LMNARECQLMEN1KMT2A | |
| SCHEMBL2772375 | 0.75 | ACHE (0.42) | LMNARECQLMEN1KMT2ACYP3A4 | |
| SCHEMBL7248268 | 0.70 | GABBR2 (0.36) | MEN1KMT2ACYP3A4 | |
| SCHEMBL21297731 | 0.69 | SERPINE1 (0.37) | — | |
| SCHEMBL8427360 | 0.69 | TPMT (0.48) | MEN1KMT2A | |
| SCHEMBL5789171 | 0.68 | ALDH1A1 (0.62) | LMNARECQLMEN1KMT2A | |
| SCHEMBL8427325 | 0.67 | TPMT (0.46) | LMNAMEN1KMT2A | |
| SCHEMBL10497616 | 0.67 | KDM4E (0.49) | LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10394122-B2 | Resist composition, method for forming resist pattern, compound, and acid generator | TOYKO OHKA KOGYO CO., LTD. (JP) | 2019-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10394122-B2 | Resist composition, method for forming resist pattern, compound, and acid generator | RB1, FXR1, CCNA1 | PTGS2 4199/4885PTGS1 3384/4885ALOX5 1440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.